Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Neoplasm × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 3 Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma, Extra-Adrenal 1 Nonhematologic Malignancies 1 Non-Squamous Non-Small Cell Lung Cancer 1 Neoplastic Cells, Circulating 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningeal Carcinomatosis 1 Malignant Solid Tumour 1

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡